Jessica Perl

CIK: 0002043716

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

EBS

Emergent BioSolutions Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

EBS
Emergent BioSolutions Inc.
Apr 29, 2026
Award(A)
Direct
104.3K shares-
EBS
Emergent BioSolutions Inc.
Mar 5, 2026
Tax Payment(F)
Direct
6.5K shares at avg. $8.44$55K
EBS
Emergent BioSolutions Inc.
Mar 3, 2026
Award(A)
Employee Stock Option (Right to buy)
Direct
46.7K shares-
EBS
Emergent BioSolutions Inc.
Feb 9, 2026
Tax Payment(F)
Direct
918 shares at avg. $11.03$10K
EBS
Emergent BioSolutions Inc.
Mar 6, 2025
Award(A)
Direct
62.5K shares-
EBS
Emergent BioSolutions Inc.
Feb 9, 2025
Tax Payment(F)
Direct
918 shares at avg. $10.00$9K

		Type	Shares	Price		Ownership
Apr 29, 2026	EBS Emergent BioSolutions Inc.	Award(A)	104,282	-	$0	Direct
Mar 5, 2026	EBS Emergent BioSolutions Inc.	Tax Payment(F)	6,465	$8.44	$54,565	Direct
Mar 3, 2026	EBS Emergent BioSolutions Inc.	Award(A) Employee Stock Option (Right to buy)	46,702	-	-	Direct
Feb 9, 2026	EBS Emergent BioSolutions Inc.	Tax Payment(F)	918	$11.03	$10,126	Direct
Mar 6, 2025	EBS Emergent BioSolutions Inc.	Award(A)	62,500	-	-	Direct
Feb 9, 2025	EBS Emergent BioSolutions Inc.	Tax Payment(F)	918	$10.00	$9,180	Direct

1-6 of 6 transactions

About Perl Jessica

Perl Jessica (SEC CIK 0002043716) files insider reports with the SEC as SVP, General Counsel, Corp Sec of Emergent BioSolutions Inc. (EBS).

Signal8 holds 6 ownership filings by Perl Jessica (1 Form 3, 5 Form 4), filed between Nov 12, 2024 and May 1, 2026. Those filings report 6 transactions, from Feb 9, 2025 to Apr 29, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Perl Jessica's filings is in GAITHERSBURG, MD.

Recent filings by Perl Jessica

Apr 29, 2026: Grant or award of EBS shares (Form 4, code A).
Mar 5, 2026: Tax withholding of EBS shares (Form 4, code F).
Mar 3, 2026: Grant or award of EBS derivative securities (Form 4, code A).
Feb 9, 2026: Tax withholding of EBS shares (Form 4, code F).
Mar 6, 2025: Grant or award of EBS shares (Form 4, code A).

Other insiders filing for Emergent BioSolutions Inc. (EBS)

DeGolyer Donald W, Director
Williams Paul Anthony, SVP, Products Business
Duatschek Stephanie, EVP, CGO
LINDAHL RICHARD S, EVP, Chief Financial Officer
Glessner Coleen, EVP, Quality & Ethics, and CPL
Hartzel William, SVP, Bioservices

How to read Form 4 transaction codes